Home/Filings/4/0001209191-19-014804
4//SEC Filing

Bernstein Karen 4

Accession 0001209191-19-014804

CIK 0001636651other

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 8:15 PM ET

Size

5.1 KB

Accession

0001209191-19-014804

Insider Transaction Report

Form 4
Period: 2019-02-26
Transactions
  • Purchase

    Common Stock

    2019-02-26$2.02/sh+10,000$20,21020,000 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.995 to 2.08 inclusive. The reporting person undertakes to provide to Ovid Therapeutics Inc., any security holder of Ovid Therapeutics Inc., or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 1 to this Form 4.

Issuer

Ovid Therapeutics Inc.

CIK 0001636651

Entity typeother

Related Parties

1
  • filerCIK 0001654055

Filing Metadata

Form type
4
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 8:15 PM ET
Size
5.1 KB